当前位置:首页 / 黛力新联合双氯芬酸钠治疗颈源性头痛近期疗效观察
论著 | 更新时间:2015-11-03
|
黛力新联合双氯芬酸钠治疗颈源性头痛近期疗效观察
Clinical study of Deanxit combined with diclofenac sodium in the treatment of cervicogenic headache

内科 201302期 页码:116-117

作者机构:广西壮族自治区民族医院神经内科,南宁市530001

基金信息:(收稿日期:2013-01-03修回日期:2013-02-24)

  • 中文简介
  • 英文简介
  • 参考文献
目的评价黛力新联合双氯芬酸钠治疗颈源性头痛的临床疗效。方法将80例颈源性头痛患者随机分为观察组(黛力新联合双氯芬酸钠)40例,对照组(单用双氯芬酸钠)40例,疗程1周,对比观察在不同时间点两组的疗效。结果在治疗开始后的第1周末,观察组患者的显效率和头痛发作频率、疼痛改善程度等方面优于对照组,两组比较差异有统计学意义(P<0.05)。结论黛力新联合双氯芬酸钠治疗颈源性头痛有肯定疗效。
ObjectiveTo evaluate the clinical effects of Deanxit combined with Diclofenac Sodium on cervicogenic headache(CHE).Method80 CHE patients were randomly divided into two groups, and the observation group(40 cases) received Deanxit combined with Diclofenac Sodium, and the control group(40 cases) treated only by Diclofenac Sodium. The course of treatment was one week, comparing the effect of the two group at different time points.ResultsObvious therapeutic effect was observed in the observation group 1 week after treatment, and the frequency of headache, degree of pain were better than that of the control group, there were significant differences between the 2 groups (P<0.05).ConclusionDeanxit combined with Diclofenac Sodium has good effect in the treatment of CHE.
  • ref

2873

浏览量

1119

下载量

0

CSCD

工具集